Ads
related to: atopic dermatitis- Before & After Photos
See the Before and After of What
A Treatment Option Can Do For You.
- Eczema Causes
Learn More About The Causes
Of Eczema (Atopic Dermatitis).
- Atopic Dermatitis
Learn About Causes, Symptoms,
& An Oral Treatment Option.
- What Is Eczema?
Find Important Facts & Information
To Understand Atopic Dermatitis.
- Sign Up for Info
Get Updates, Answers, and Resources
For Treatment Support
- Take Our Symptoms Quiz
Take Our Quiz To Learn
About Your Symptoms.
- Before & After Photos
Search results
Earnings call: Nektar Therapeutics optimistic on REZPEG and pipeline progress By Investing.com
Investing.com· 6 hours agoNektar Therapeutics (NASDAQ:NKTR) reported a productive first quarter of 2024, focusing on their...
Earnings call: Aclaris Therapeutics progresses with atopic dermatitis study By Investing.com
Investing.com· 2 days ago:ACRS) has announced during its First Quarter 2024 Conference Call that it will advance ATI-2138,...
Systemic antibiotics in first year of life tied to higher atopic dermatitis risk
Medical Xpress· 2 days agoSystemic antibiotic exposure in the first year of life is associated with higher atopic dermatitis...
BofA bullish on Apogee stock, sees significant market growth potential By Investing.com
Investing.com· 8 hours agoFriday, BofA Securities initiated coverage on Apogee (NASDAQ:APOG) Therapeutics Inc (NASDAQ:APGE)...
RAPT Therapeutics Shares Hit 52-Week Low After Trials Closed
Morningstar· 1 day agoThe immunology-based therapeutics company said it has decided to close and unblind both its Phase 2b clinical trial of zelnecirnon in atopic dermatitis ...
Warner Bros. upgraded, Cerence downgraded: Wall Street's top analyst calls
The Fly via Yahoo Finance· 8 hours agoBofA initiated coverage of Apogee Therapeutics (APGE) with a Buy rating and $80 price target. The...
Jefferies raises Nektar Therapeutics stock target, maintains hold By Investing.com
Investing.com· 4 hours agoThe adjustment comes as Nektar Therapeutics progresses with its clinical trials. The company is...
...Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients During Virtual...
Benzinga· 3 days agoThe KOL event, "Treatment Options for Atopic Dermatitis Patients with an Inadequate Response to Dupilumab: Exploring the ...
What's Going On With Dermatitis-Focused RAPT Therapeutics Stock On Thursday?
Benzinga via Yahoo Finance· 1 day agoOn Thursday, RAPT Therapeutics Inc. (NASDAQ:RAPT) announced that it has decided to close and unblind...
Nektar's (NKTR) Q1 Earnings and Revenues Surpass Estimates
Zacks via Yahoo Finance· 6 hours agoRezpeg is now a wholly owned asset of Nektar and the company owes no royalty payments to LLY. A...
Ads
related to: atopic dermatitis
